Author:
Tapiawala Shruti N.,Bargman Joanne M.,Oreopoulos Dimitrios G.,Simons Martin
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Combet S, Van Landschoot M, Moulin P (2000) Vascular proliferation and enhanced expression of endothelial nitric oxide synthetase in human peritoneum exposed to long term peritoneal dialysis. J Am Soc Nephrol 11:717–728
2. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O (2007) Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356(2):115–124. doi: 10.1056/NEJMoa065044
3. Rock EP, Goodman V, Jiang J, Mahjoor K, Verbois SL, Morse D, Dagher R, Justice R, Padzur R (2007) Food and drug administration drug approval summary: Sunitinib Maleate for treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma. Oncologist 12:107–113. doi: 10.1634/theoncologist.12-1-107
4. Chow LQ, Eckhardt SG (2007) Sunitinib: from rational design to clinical efficacy. J Clin Oncol 7(25):884–896. doi: 10.1200/JCO.2006.06.3602
5. Yoko Y, Masanobu M, Katsushige A, Tomoya N, Akira F, Yoshei M, Takashi H, Yoshiyuki O, Takehiko K, Shigeru (2004) TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model. Kidney Int (66):1677–1685
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献